---
$id: https://graph.org.ai/products/commodity/51282944
$type: Product
source: UNSPSC
code: "51282944"
title: "Sparfloxacin"
class: "51282900"
classTitle: "Quinolone antibacterials"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Sparfloxacin

**UNSPSC Code**: 51282944
**Class**: [Quinolone antibacterials](Quinolone antibacterials.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a quinolone antibiotic and antitubercular agent with the molecular formula C19H22F2N4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Q90AGA787L, chemically known as 5-amino-1-cyclopropyl-7-(3,5-dimethyl-1-piperazinyl)-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid, but generally known as sparfloxacin, which bears US NIH Compound Identifier 5257. European Medicines Agency schedules Sparfloxacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10610MIG. The term SPARFLOXACIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, No. 3 1991, List 31). World Health Organization schedules sparfloxacin in its Anatomical Therapeutic Chemical (ATC) Classification. SPARFLOXACIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule sparfloxacin under HS 29335995 and SITC 51576. As of Q4 2014, SPARFLOXACIN remains the US FDA Preferred Term for this commodity. Sparfloxacin bears US NLM identifiers UMLS ID C0052585 and NCI Concept Code C61950. SMILES: FC1C2N(C3CC3)CC(C(=O)C2C(N)C(F)C1N1CC(NC(C1)C)C)C(=O)O.

